Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of Albumin Dialysis Using Prometheus in End Stage Renal Disease: Detoxification Capacity and Impact on Vascular Endothelial Function

NCT00442299 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.

NCT NCT00442299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00442299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of Albumin Dialysis Using Prometheus in End Stage Renal Disease: Detoxification Capacity and Impact on Vascular Endothelial Function
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Phase
Phase 1/2
Overall status
Suspended
Start date
April 30, 2005
Completion date
December 31, 2009
Enrollment
10
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease